Patient#	Sample#	GDP:(GTP, active),(Gi family/GNB1/GNG2/GDP, active),(HRAS/GDP, active),(RAC1-CDC42/GDP, active),	GNB1/GNG2:(GTP, active),(Gi family/GNB1/GNG2/GDP, active),	IP3:(PI-4-5-P2, active),	PI3K:(T-DHT, active),	RAC1-CDC42/GTP:(GTP, active),(PI3K, active),(RAC1-CDC42/GDP, active),	AKT1:(AKT1, protein),(T-DHT, active),	AR:(AR, protein),	ERK1-2:(ERK1-2, protein),	FAK:(FAK, protein),(T-DHT, active),	GNRH1:(GNRH1, protein),(T-DHT, active),	MAPK1:(MAPK1, protein),(T-DHT, active),	MEK1-2:(MEK1-2, protein),	PELP1:(PELP1, protein),	SHBG:(SHBG, protein),	SRC:(SRC, protein),	actin cytoskeleton reorganization:(RAC1-CDC42/GTP, active),	PLC:(PLC, protein),(T-DHT, active),	SHBG/T-DHT:(G-protein coupled receptor activity, active),(SHBG, active),(T-DHT, active),	T-DHT/AR:(AR, active),(T-DHT, active),	DAG:(PI-4-5-P2, active),(PLC, active),	Gi family/GTP:(GTP, active),(Gi family/GNB1/GNG2/GDP, active),(T-DHT, active),(T-DHT/AR, active),	T-DHT/AR/PELP1:(PELP1, active),(T-DHT/AR, active),	Ca2+:(Gi family/GTP, active),(IP3, active),(potassium channel inhibitor activity, active),(voltage-gated calcium channel activity, active),	T-DHT/AR/PELP1/Src:(SRC, active),(T-DHT/AR/PELP1, active),	cAMP biosynthetic process:(Gi family/GTP, active),(SHBG/T-DHT, active),	HRAS/GTP:(GTP, active),(HRAS/GDP, active),(T-DHT/AR/PELP1/Src, active),	T-DHT/AR/PELP1/Src/PI3K:(PI3K, active),(T-DHT/AR/PELP1/Src, active),	RAF1:(HRAS/GTP, active),(RAF1, protein),	regulation of S phase of mitotic cell cycle:(T-DHT/AR/PELP1/Src/PI3K, active),	MEK1-2-active:(MEK1-2, active),(MEK1-2-active, protein),(RAF1, active),	ERK1-2-active:(Ca2+, active),(ERK1-2, active),(ERK1-2-active, protein),(MEK1-2-active, active),	CREB1:(CREB1, protein),(ERK1-2-active, active),	cell proliferation:(ERK1-2-active, active),	apoptosis:(CREB1, active),	FOS:(FOS, protein),	
